135 related articles for article (PubMed ID: 9163562)
1. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
Idänpään-Heikkilä JJ; Perrot S; Guilbaud G; Kayser V
Eur J Pharmacol; 1997 May; 325(2-3):155-64. PubMed ID: 9163562
[TBL] [Abstract][Full Text] [Related]
2. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
[TBL] [Abstract][Full Text] [Related]
3. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
4. The enhancement of morphine antinociception by a CCKB receptor antagonist in the rat depends on the phase of inflammation and the intensity of carrageenin-induced hyperalgesia.
Perrot S; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Pain; 1998 Feb; 74(2-3):269-74. PubMed ID: 9520241
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
Yamamoto T; Sakashita Y
Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
[TBL] [Abstract][Full Text] [Related]
6. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
Friedrich AE; Gebhart GF
J Pharmacol Exp Ther; 2000 Feb; 292(2):538-44. PubMed ID: 10640290
[TBL] [Abstract][Full Text] [Related]
7. The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats.
Kayser V; Idänpään-Hekkilä JJ; Christensen D; Guilbaud G
Life Sci; 1998; 62(10):947-52. PubMed ID: 9496717
[TBL] [Abstract][Full Text] [Related]
8. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A
Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy.
Kayser V; Lee SH; Guilbaud G
Neuroscience; 1995 Jan; 64(2):537-45. PubMed ID: 7700537
[TBL] [Abstract][Full Text] [Related]
11. Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats.
Lee SH; Kayser V; Desmeules J; Guilbaud G
Pain; 1994 May; 57(2):233-240. PubMed ID: 8090518
[TBL] [Abstract][Full Text] [Related]
12. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors.
Catheline G; Kayser V; Guilbaud G
Eur J Pharmacol; 1996 Nov; 315(2):135-43. PubMed ID: 8960876
[TBL] [Abstract][Full Text] [Related]
13. L-740,093, a new antagonist of the CCK-B receptor, potentiates the antinociceptive effect of morphine: electrophysiological and behavioural studies.
Xu XJ; Hoffmann O; Wiesenfeld-Hallin Z
Neuropeptides; 1996 Apr; 30(2):203-6. PubMed ID: 8771563
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
[TBL] [Abstract][Full Text] [Related]
15. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
[TBL] [Abstract][Full Text] [Related]
16. Systemic clonidine differentially modulates the abnormal reactions to mechanical and thermal stimuli in rats with peripheral mononeuropathy.
Kayser V; Desmeules J; Guilbaud G
Pain; 1995 Mar; 60(3):275-85. PubMed ID: 7596623
[TBL] [Abstract][Full Text] [Related]
17. Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat.
Ossipov MH; Kovelowski CJ; Vanderah T; Porreca F
Neurosci Lett; 1994 Nov; 181(1-2):9-12. PubMed ID: 7898778
[TBL] [Abstract][Full Text] [Related]
18. The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery.
Christensen D; Kayser V
Pain; 2000 Dec; 88(3):231-238. PubMed ID: 11068110
[TBL] [Abstract][Full Text] [Related]
19. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
Martinez V; Christensen D; Kayser V
Pain; 2002 Oct; 99(3):537-545. PubMed ID: 12406530
[TBL] [Abstract][Full Text] [Related]
20. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.
Dourish CT; O'Neill MF; Coughlan J; Kitchener SJ; Hawley D; Iversen SD
Eur J Pharmacol; 1990 Jan; 176(1):35-44. PubMed ID: 2311658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
